A Phase 1 Study of LNCB74 in Advanced Solid Tumors
NCT06774963
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
145
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Breast Cancer
Endometrial Cancer
Biliary Tract Cancer
Non-Small Cell Lung Cancer
Advanced or Metastatic Solid Tumors
Interventions
DRUG:
LNCB74
Sponsor
NextCure, Inc.
Collaborators
[object Object]